Combining azole antifungals with venetoclax plus azacitidine in patients with newly diagnosed acute myeloid leukemia
The combination of venetoclax (VEN) with hypomethylating agents (HMAs) improves survival in patients with acute myeloid leukemia (AML) and may cause neutropenia requiring combined antifungal therapy or prophylaxis. The inhibition of cytochrome P450 activity by azole antifungal agents leads to elevat...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2024-12-01
|
| Серія: | Hematology |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2433172 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|